| Product Code: ETC13337950 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Europe Infectious Vaccines Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Europe Infectious Vaccines Market Overview |
3.1 Europe Regional Macro Economic Indicators |
3.2 Europe Infectious Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Europe Infectious Vaccines Market - Industry Life Cycle |
3.4 Europe Infectious Vaccines Market - Porter's Five Forces |
3.5 Europe Infectious Vaccines Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Europe Infectious Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Europe Infectious Vaccines Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Europe Infectious Vaccines Market Revenues & Volume Share, By End-Use, 2021 & 2031F |
3.9 Europe Infectious Vaccines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Europe Infectious Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Europe Infectious Vaccines Market Trends |
6 Europe Infectious Vaccines Market, 2021 - 2031 |
6.1 Europe Infectious Vaccines Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Europe Infectious Vaccines Market, Revenues & Volume, By Live Attenuated Vaccines, 2021 - 2031 |
6.1.3 Europe Infectious Vaccines Market, Revenues & Volume, By Inactivated Vaccines, 2021 - 2031 |
6.1.4 Europe Infectious Vaccines Market, Revenues & Volume, By mRNA Vaccines, 2021 - 2031 |
6.2 Europe Infectious Vaccines Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Europe Infectious Vaccines Market, Revenues & Volume, By COVID-19, 2021 - 2031 |
6.2.3 Europe Infectious Vaccines Market, Revenues & Volume, By Influenza, 2021 - 2031 |
6.2.4 Europe Infectious Vaccines Market, Revenues & Volume, By Hepatitis, 2021 - 2031 |
6.3 Europe Infectious Vaccines Market, Revenues & Volume, By End-Use, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Europe Infectious Vaccines Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.3 Europe Infectious Vaccines Market, Revenues & Volume, By Pharmacies, 2021 - 2031 |
6.3.4 Europe Infectious Vaccines Market, Revenues & Volume, By Government Immunization Programs, 2021 - 2031 |
6.4 Europe Infectious Vaccines Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Europe Infectious Vaccines Market, Revenues & Volume, By Public Health Agencies, 2021 - 2031 |
6.4.3 Europe Infectious Vaccines Market, Revenues & Volume, By Private Clinics, 2021 - 2031 |
7 Europe Infectious Vaccines Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Europe Infectious Vaccines Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.1 United Kingdom (UK) Infectious Vaccines Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.2 Germany Infectious Vaccines Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.3 France Infectious Vaccines Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.4 Poland Infectious Vaccines Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.5 Spain Infectious Vaccines Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.6 Rest of Europe Infectious Vaccines Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3 Europe Infectious Vaccines Market Revenues & Volume Share, By Application, 2021 & 2031F |
7.3.1 United Kingdom (UK) Infectious Vaccines Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.2 Germany Infectious Vaccines Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.3 France Infectious Vaccines Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.4 Poland Infectious Vaccines Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.5 Spain Infectious Vaccines Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3.6 Rest of Europe Infectious Vaccines Market, Revenues & Volume, By Application, 2021 - 2031 |
7.4 Europe Infectious Vaccines Market, Revenues & Volume, By End-Use, 2021 - 2031 |
7.4.1 United Kingdom (UK) Infectious Vaccines Market, Revenues & Volume, By End-Use, 2021 - 2031 |
7.4.2 Germany Infectious Vaccines Market, Revenues & Volume, By End-Use, 2021 - 2031 |
7.4.3 France Infectious Vaccines Market, Revenues & Volume, By End-Use, 2021 - 2031 |
7.4.4 Poland Infectious Vaccines Market, Revenues & Volume, By End-Use, 2021 - 2031 |
7.4.5 Spain Infectious Vaccines Market, Revenues & Volume, By End-Use, 2021 - 2031 |
7.4.6 Rest of Europe Infectious Vaccines Market, Revenues & Volume, By End-Use, 2021 - 2031 |
7.5 Europe Infectious Vaccines Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5.1 United Kingdom (UK) Infectious Vaccines Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5.2 Germany Infectious Vaccines Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5.3 France Infectious Vaccines Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5.4 Poland Infectious Vaccines Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5.5 Spain Infectious Vaccines Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5.6 Rest of Europe Infectious Vaccines Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Europe Infectious Vaccines Market Key Performance Indicators |
9 Europe Infectious Vaccines Market - Export/Import By Countries Assessment |
10 Europe Infectious Vaccines Market - Opportunity Assessment |
10.1 Europe Infectious Vaccines Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Europe Infectious Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F |
10.3 Europe Infectious Vaccines Market Opportunity Assessment, By Application, 2021 & 2031F |
10.4 Europe Infectious Vaccines Market Opportunity Assessment, By End-Use, 2021 & 2031F |
10.5 Europe Infectious Vaccines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
11 Europe Infectious Vaccines Market - Competitive Landscape |
11.1 Europe Infectious Vaccines Market Revenue Share, By Companies, 2022 |
11.2 Europe Infectious Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here